GlassScriptPhysician profile
Sarah N Morris
NPI 1144221540
$4,067.56
in general payments reported to CMS, 2019-2025
35 companies · $721 in 2025
The $721 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $513 · 2020: $66.52 · 2021: $113 · 2022: $1,347 · 2023: $761 · 2024: $547 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,028.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $538.91 | 2019-2024 | |
| Astellas Pharma US INC | $479.91 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $375.17 | 2022-2025 | |
| Aspira Women'S Health INC | $268.49 | 2022-2023 | Ova1 |
| Organon LLC | $259.61 | 2022-2025 | Nexplanon, Jada System |
| Pfizer INC. | $242.50 | 2019-2024 | |
| Daiichi Sankyo INC. | $212.15 | 2019-2025 | Injectafer |
| Novo Nordisk INC | $191.08 | 2023-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $138.17 | 2019-2024 | |
| Exeltis, USA INC. | $122.32 | 2021-2025 | Slynd |
| Sumitomo Pharma America, INC. | $104.63 | 2023-2025 | Myfembree, Gemtesa |
| Exact Sciences Corporation | $87.82 | 2023-2024 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $85.70 | 2019-2020 | |
| Coopersurgical, INC. | $81.78 | 2024-2025 | Paragard T 380a |
| Channel Medsystems, INC. | $77.91 | 2022-2025 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $74.92 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Mylan Pharmaceuticals INC. | $70.61 | 2019-2022 | |
| Agile Therapeutics, INC. | $69.94 | 2022 | |
| Lilly USA, LLC | $69.73 | 2025 | Zepbound, Mounjaro |
| Sage Therapeutics, LLC | $64.74 | 2023-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $56.21 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Therapeuticsmd, INC. | $49.32 | 2019-2022 | |
| Shield Therapeutics INC | $47.43 | 2023-2024 | Accrufer |
| Scynexis, INC. | $42.61 | 2022 | |
| Evofem Biosciences, INC. | $38.43 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $35.53 | 2019 | |
| Myovant Sciences INC. | $33.14 | 2022 | |
| Welch Allyn | $32.94 | 2019 | |
| Amgen INC. | $28.48 | 2024 | Evenity, Prolia |
| Smith+Nephew, INC. | $23.60 | 2022 | |
| Vertical Pharmaceuticals, LLC | $17.30 | 2019 | |
| Merck Sharp & Dohme LLC | $12.26 | 2019 | |
| Duchesnay USA Incorporated | $11.67 | 2019 | |
| Mission Pharmacal Company | $11.37 | 2019 | |
| Allergan, INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.